• Home
  • Stocks
  • Krishna Institute of Medical Sciences Ltd

Krishna Institute of Medical Sciences Ltd
Snapshot View

View in App

Prices View details >>

1435.00 -49.50 ▼-3.3%

07 October 2022, 04:01:00 PM
Volume: 2,745

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kimshospitals.com
Market Cap 11,483.99 Cr.
Enterprise Value(EV) 11,895.50 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 39.18 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 36.63 Trailing Twelve Months Ending 2022-06
Industry PE 50.40 Trailing Twelve Months Ending 2022-06
Book Value / Share 183.26 Trailing Twelve Months Ending 2022-06
Price to Book Value 7.83 Calculated using Price: 1,435.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 8.00 Cr. 80,027,787 Shares
FaceValue 10
Company Profile
The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.33%
1 Week
-5.12%
1 Month
+12.59%
3 Month
+17.90%
6 Month
+2.15%
1 Year
+19.77%
2 Year
5 Year
10 Year

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 2.25 3.31 11.15 -94.27 -25.44 20.22 28.12 29.70
Return on Capital Employed (%) 10.41 9.91 14.96 5.18 12.42 4.99 21.17 30.82 34.98
Return on Assets (%) 0.73 1.11 4.23 -9.91 -5.71 -4.80 9.97 15.64 20.03

Balance Sheet View Details >>

Particulars 4 years 2015-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 238 598 864 1,387
Non Curr. Liab. 243 364 279 278
Curr. Liab. 170 219 278 215
Minority Int. 6 13 12 23
Equity & Liab. 657 1,194 1,433 1,904
Non Curr. Assets 557 975 982 1,511
Curr. Assets 101 220 451 393
Misc. Exp. not W/O
Total Assets 657 1,194 1,433 1,904

Profit Loss View Details >>

Particulars 5 years 2015-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 420 1,123 1,330 1,651 1,673
Other Income 4 6 10 20 21
Total Income 424 1,129 1,340 1,671 1,694
Total Expenditure -342 -873 -954 -1,129 -1,164
PBIDT 81 256 386 542 531
Interest -35 -44 -37 -22 -15
Depreciation -32 -71 -70 -73 -85
Taxation -7 -25 -74 -113 -109
Exceptional Items
PAT 7 115 205 334 322
Minority Interest -1 4 -4 -11 -17
Share Associate -1 10 10
Other Related Items
Consolidated Net Profit 6 119 201 333 314
Adjusted EPS 6 16 26 42 39

Cash Flow View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 202 356 324
Cash Fr. Inv. -125 -354 -412
Cash Fr. Finan. -44 10 61
Net Change 32 12 -27
Cash & Cash Eqvt 41 52 26

Shareholding Pattern View Details >>

9 Qtrs 2017-08 (%) 2018-09 (%) 2019-03 (%) 2020-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 54.80 54.80 46.01 44.59 38.84 38.84 38.84 38.84 38.84
Public 45.20 45.20 53.99 55.41 61.16 61.16 61.16 61.16 61.16
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 13.45 13.45 14.86 15.74

Announcements View Details >>

Thu, 29 Sep 2022
Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 (as amended) and the Companys Code of Conduct for Prevention of Insider Trading the trading window of the Company will remain closed for all Connected Persons/Designated Persons and their immediate relatives to deal in the securities of the Company from Saturday 1st October 2022 till 48 hours after the declaration of Unaudited Financial Results (UFR) of the Company for the quarter and half year ending on September 30 2022.
Thu, 22 Sep 2022
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform that IIFL Securities has arranged a few investors visit at recently acquired hospital i.e. Kingsway Hospitals Nagpur on Monday 26th September 2022. This will be followed by management interaction.
Mon, 12 Sep 2022
Announcement under Regulation 30 (LODR)-Acquisition
In Continuation to the intimation dated 30th September 2022 it is being informed that the Company has acquired 51% stake in Spanv Medisearch Lifesciences Private Limited (Kingsway Hospitals) and the shares of the Kingsway Hospitals were credited in the Demat A/c of the Company.

Technical Scans View Details >>

Thu, 06 Oct 2022
Higher Trade Quantity Higher Trade Quantity
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
RSI Crossed Above 70 RSI Crossed Above 70

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 953.00 -0.1%
Divi's Laboratories Ltd. 99,171.10 3,738.70 +0.0%
Cipla Ltd. 91,534.16 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,831.42 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.78 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.26 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Krishna Institute of Medical Sciences Ltd

What is Krishna Inst.Medi share price?
Can I buy Krishna Inst.Medi shares now?
What is the Market Cap of Krishna Inst.Medi?
What are the key metrics to analyse Krishna Inst.Medi?
What is the 52 Week High and Low of Krishna Inst.Medi?
What is the trend of Krishna Inst.Medi share price?